Babyshkina, N. N., Dronova, T. A., Zambalova, E. A., Zavyalova, M. V., Slonimskaya, E. M., & Cherdyntseva, N. V. (2020). The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients. Бюллетень сибирской медицины, 19(1), 13-20. https://doi.org/10.20538/1682-0363-2020-1-13-20
Chicago-referens (17:e uppl.)Babyshkina, N. N., T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, och N. V. Cherdyntseva. "The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Patients." Бюллетень сибирской медицины 19, no. 1 (2020): 13-20. https://doi.org/10.20538/1682-0363-2020-1-13-20.
MLA-referens (9:e uppl.)Babyshkina, N. N., et al. "The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Patients." Бюллетень сибирской медицины, vol. 19, no. 1, 2020, pp. 13-20, https://doi.org/10.20538/1682-0363-2020-1-13-20.
